Musculoskeletal events associated with the management of endocrine-responsive breast cancer

ISSN： 1970-5557

Source： Oncology Reviews, Vol.4, Iss.3, 2010-09, pp. : 185-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 13, 2018-01 ,pp. : 1805-1813

Bentham Science Publishers

Access to resources Recommend Favorite

New Endocrine Therapies for Breast Cancer

By Howell A. Downey S. Anderson E.

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 576-588

Elsevier

Access to resources Recommend Favorite

Resistance to endocrine therapy in breast cancer

By Kurebayashi Junichi

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Multiple endocrine neoplasia type 1 associated with breast cancer: A case report and review of the literature

By Jeong Young Ju Oh Hoon Kyu Bong Jin Gu

Oncology Letters, Vol. 8, Iss. 1, 2014-07 ,pp. : 230-234

Spandidos Publications

Access to resources Recommend Favorite

Neoadjuvant endocrine therapy of breast cancer: a surgical perspective

By Dixon J.M. Anderson T.J. Miller W.R.

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2214-2221

Elsevier

Access to resources Recommend Favorite